Zydus acquires the gastro therapy 'Actibile' from Albert David

Strengthens its presence in the gastroenterology segment


The deal will be financed through internal accruals

The Zydus Group, an innovation-led global healthcare provider announced that Zydus Healthcare Limited, a wholly owned subsidiary of Cadila Healthcare Limited has entered into a definitive agreement to acquire "Actibile‟ from Albert David Limited (ADL).

ADL is listed on the Bombay Stock Exchange and is involved in manufacturing and marketing of branded formulations in India and abroad and also has operations in medical disposables.

The brand falls in the gastroenterology segment and is used for dissolving gall bladder stones. The deal will be financed through internal accruals.

Speaking on the development, chairman and managing director of the group, Mr Pankaj R Patel said, "The gastrointestinal segment has been one of our core focus segments and we have been working with the medical fraternity to serve patient needs better. I believe that this acquisition will strengthen our portfolio of brands and leverage our equity in this key segment."


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email